Bilcare - Packing A Punch

Bilcare Net Sales Up 40% PAT Up 54%

Bilcare Ltd., India’s leading pharma major in the drug discovery to market value chain, announced their Q3 results for FY 06-07, today.

The company has recorded sales of Rs. 834.7 million, PBT of Rs. 215.5 million and PAT of Rs. 142.0 million for the quarter ended 31 December 2006. The sales of the company has recorded a growth 40% while PAT has shown an increase of 54% over the corresponding quarter in the previous year.

Announcing the company’s Q3 results, Mr. Mohan Bhandari, Chairman & Managing Director said, “Bilcare continues to focus on the research and technology aspects to provide innovative packaging solutions to the global pharmaceutical industry. We are progressively entering into technical collaborations with companies across the globe that will partner with us to provide solutions to the issues faced by the industry. Recently, Bilcare announced a regional collaboration with US-based Honeywell’s Specialty Films Business to Develop Value-based Pharma Packaging Solutions.”

Bilcare continues to revolutionize the pharma industry through innovative products. The highlight being the winning of the patent in the USA for its pharmaceutical grade thermo-formable composite films. The innovative packaging material will address multiple concerns and limitations of the pharmaceutical products in the market like anti-counterfeit and anti-pass off. The unique products under this range are Patina, Ultra and Ultra TX.

Bilcare Research will continue to focus on key areas of developments like clinical research, clinical supplies and pharma packaging and looking at global prospects for expanding in these fields.